Comments
Sun Pharma Advanced Research Company has said that Abraxis Biosciences LLC has filed a complaint against the company in the US District Court (New Jersey).
It has alleged that SPARC’s filing of the New Drug Application for Taclantis injection (Paclitaxel Injection Concentrate for Suspension) is an act of infringement of the orange book listed patents for Abraxane.
“SPARC believes that this lawsuit is without merit and will vigorously defend against these allegations.”
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.